Longitudinal Hemodynamic Changes in Pediatric Patients with Severe Pulmonary Arterial Hypertension (PAH) on Prostanoid Therapy

被引：0
|
作者：
Siehr, S. L. [1 ]
Ivy, D. [2 ]
Miller-Reed, K. [2 ]
Ogawa, M. [1 ]
Rosenthal, D. [1 ]
Feinstein, J. A. [1 ]
机构：
[1] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA
[2] Univ Colorado Denver, Childrens Hosp, Aurora, CO USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1016/j.healun.2011.01.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
197
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [1] Prostanoid therapy for pulmonary arterial hypertension
    Strauss, Wayne L.
    Edelman, Jeffrey D.
    [J]. CLINICS IN CHEST MEDICINE, 2007, 28 (01) : 127 - +
  • [2] Prostanoid therapy for pulmonary arterial hypertension
    Badesch, DB
    McLaughlin, VV
    Delcroix, M
    Vizza, CD
    Olschewski, H
    Sitbon, O
    Barst, RJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) : 56S - 61S
  • [3] Hemodynamic effects of sildenafil citrate in patients with pulmonary arterial hypertension (PAH)
    Rubin, L
    Burgess, G
    Parpia, T
    Burst, R
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 93A - 94A
  • [4] Longitudinal Effects of Initiation of Parenteral Prostanoid Therapy for the Treatment of Pulmonary Arterial Hypertension, The Pulmonary Hypertension Association Registry
    Pan, H.
    Argula, R. G.
    Badesch, D. B.
    De Marco, T.
    Elwing, J. M.
    Grinnan, D.
    Lammi, M. R.
    Mazimba, S.
    Raval, A. A.
    Ryan, J. J.
    Shlobin, O. A.
    Thenappan, T.
    Mathai, S. C.
    Leary, P. J.
    Al-Naamani, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [5] Targeted Therapy of pulmonary arterial Hypertension (PAH)
    Klose, H.
    Opitz, C.
    Bremer, H.
    Ewert, R.
    Bonderman, D.
    Rosenkranz, S.
    Seeger, W.
    Schmeisser, A.
    Harbaum, L.
    Buerke, M.
    Ghofrani, H. Ardeschir
    Borst, M. M.
    Leuchte, H. H.
    Lange, T. J.
    Behr, J.
    Ulrich, S.
    Lang, I.
    Olschewski, H.
    Gall, H.
    Kabitz, H. -J.
    Kleber, F. -X.
    Held, M.
    Hoeper, M. M.
    Gruenig, E.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S142 - S150
  • [6] The VEGF Paradox Of Severe Pulmonary Arterial Hypertension (pah)
    Al Husseini, A.
    Farkas, D.
    Drake, J. I.
    Gomez-Arroyo, J. G.
    Kraskauskas, D.
    Voelkel, N. F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Advances in Prostanoid Infusion Therapy for Pulmonary Arterial Hypertension
    Doran, Aimee
    Harris, Stephanie
    Goetz, Brett
    [J]. JOURNAL OF INFUSION NURSING, 2008, 31 (06) : 336 - 345
  • [8] Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
    Calcaianu, George
    Schuller, Armelle
    Chaouat, Ari
    Canuet, Matthieu
    Kessler, Romain
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [9] Sequential combination therapy in pulmonary arterial hypertension (PAH)
    Keogh, A.
    Kotlyar, E.
    Macdonald, P.
    Hayward, C.
    Corrigan, C.
    Pidoux, A.
    Brown, K.
    Williams, T.
    Gabbay, E.
    McNeil, K.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S186 - S186
  • [10] Inhaled prostanoid therapy for pulmonary arterial hypertension - a promise unfulfilled?
    Ramani, Gautam V.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (07) : 923 - 925
12345